CAS: 439087-18-0 - Elobixibat
Formula:C36H45N3O7S2
InChI:InChI=1S/C36H45N3O7S2/c1-4-6-18-36(19-7-5-2)24-39(27-16-12-9-13-17-27)28-20-30(47-3)29(21-31(28)48(44,45)25-36)46-23-32(40)38-34(26-14-10-8-11-15-26)35(43)37-22-33(41)42/h8-17,20-21,34H,4-7,18-19,22-25H2,1-3H3,(H,37,43)(H,38,40)(H,41,42)/t34-/m1/s1
InChI key:InChIKey=XFLQIRAKKLNXRQ-UUWRZZSWSA-N
SMILES:O=C(O)CNC(=O)C(NC(=O)COC=1C=C2C(=CC1SC)N(C=3C=CC=CC3)CC(CCCC)(CCCC)CS2(=O)=O)C=4C=CC=CC4
- Synonyms:
- Glycine, (2R)-N-[[[3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- AZD 7806
- Glycine, (2R)-N-[2-[[3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl-
- Elobixibat
- (2R)-N-[2-[[3,3-Dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycylglycine
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Elobixibat REF: 4Z-E-197001CAS: 439087-18-0 | - - - | To inquire | Thu 05 Dec 24 |
 | Elobixibat REF: TR-E505200CAS: 439087-18-0 | - - - | 16,799.00 € | Tue 14 Jan 25 |
 | Elobixibat REF: 3D-PSA08718CAS: 439087-18-0 | Min. 95% | 364.00 €~1,739.00 € | Wed 15 Jan 25 |
 | Elobixibat REF: TM-T15209CAS: 439087-18-0 | 97.43% - 97.47% | 95.00 €~2,173.00 € | Wed 05 Feb 25 |
Ref: 4Z-E-197001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Elobixibat
Controlled ProductCAS:439087-18-0
Formula:
C36H45N3O7S2
Color and Shape:
Neat
Molecular weight:
695.888
Ref: TR-E505200
| 25mg | 16,799.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Elobixibat
CAS:439087-18-0
Elobixibat is a drug that has been studied for its potential to treat cancer, chronic …
Formula:
C36H45N3O7S2
Purity:
Min. 95%
Molecular weight:
695.9 g/mol
Ref: 3D-PSA08718
| 1mg | 517.00 € | ||
| 2mg | 801.00 € | ||
| 5mg | 1,160.00 € | ||
| 10mg | 1,739.00 € | ||
| 500µg | 364.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Elobixibat
CAS:439087-18-0
Elobixibat (A 3309) blocks IBAT in mice/humans/dogs (IC50: 0.13/0.53/5.8 nM); used for constipation research.
Formula:
C36H45N3O7S2
Purity:
97.43% - 97.47%
Color and Shape:
Solid
Molecular weight:
695.89
Ref: TM-T15209
| 1mg | 95.00 € | ||
| 5mg | 401.00 € | ||
| 10mg | 682.00 € | ||
| 25mg | 1,237.00 € | ||
| 50mg | 1,668.00 € | ||
| 100mg | 2,173.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025
